Refined association of TSH receptor susceptibility locus to Graves' disease in the Chinese Han population

Eur J Endocrinol. 2014 Jan 1;170(1):109-19. doi: 10.1530/EJE-13-0517. Print 2014 Jan.

Abstract

Background: Convincing evidence has demonstrated the association of TSH receptor (TSHR) with Graves' disease (GD) in the Chinese Han population.

Objective: The aim of this study was to identify the causal variants for GD in the region encompassing TSHR by a refining association study.

Design and methods: GD patients (1536) and 1516 sex-matched controls were recruited in the first stage, and an additional 3832 GD patients and 3426 sex-matched controls were recruited in the replication stage. Genotyping was performed using Illumina Human660-Quad BeadChips or TaqMan single nucleotide polymorphism (SNP) Genotyping Assays and the Fluidigm EP1 platform.

Results: When the results of regression analysis for 74 genotyped SNPs and 922 imputed SNPs in the first-stage cohort were combined, rs179243 and rs3783949 were the probable susceptibility SNPs associated with GD in TSHR. Eleven SNPs, including rs179243 and rs3783949, were selected to further refine the association in the replication study. Finally, rs12101261 and rs179243 were confirmed as independent GD susceptibility variants in the replication and combined populations. Further, we also found that the rate of persistent TSHR autoantibody positivity (pTRAb+) was significantly higher in the GD patients with the susceptible genotypes rs12101261 or rs179243 than in the GD patients carrying the protective genotypes, after the GD patients had been treated for more than 1 year.

Conclusions: These findings indicate that rs12101261 and rs179243 are the possible causal SNPs for GD susceptibility in the TSHR gene and could serve as genetic markers to predict the outcome of pTRAb+ in GD patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antithyroid Agents / therapeutic use
  • Asian People
  • Case-Control Studies
  • China
  • Cohort Studies
  • Combined Modality Therapy
  • Drug Resistance
  • Female
  • Genetic Association Studies
  • Genetic Loci
  • Genetic Predisposition to Disease*
  • Graves Disease / genetics*
  • Graves Disease / immunology
  • Graves Disease / metabolism
  • Graves Disease / therapy
  • Humans
  • Immunoglobulins, Thyroid-Stimulating / analysis
  • Iodine Radioisotopes / therapeutic use
  • Male
  • Polymorphism, Single Nucleotide*
  • Radiopharmaceuticals / therapeutic use
  • Receptors, Thyrotropin / antagonists & inhibitors
  • Receptors, Thyrotropin / genetics*
  • Receptors, Thyrotropin / metabolism
  • Reproducibility of Results

Substances

  • Antithyroid Agents
  • Immunoglobulins, Thyroid-Stimulating
  • Iodine Radioisotopes
  • Radiopharmaceuticals
  • Receptors, Thyrotropin
  • thyrotropin-binding inhibitory immunoglobulin